Citigroup’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Citigroup's JAZZ Position: Q3 2026 in Review
Citigroup reduced its Jazz Pharmaceuticals (JAZZ) stake by 67% in Q3 2026, selling an estimated $26.3M and leaving 51,454 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.
Citigroup first reported a position in JAZZ in Q2 2013 and has held it in 54 quarters since. The position peaked at $38M in Q2 2026. 671 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Citigroup held 51,454 shares of Jazz Pharmaceuticals worth $11.9M as of Q3 2026.
- Citigroup sold 106,272 Jazz Pharmaceuticals shares in Q3 2026, an estimated $26.3M.
- Jazz Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1499 holding.
- Citigroup first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 54 quarters since.
- Citigroup's Jazz Pharmaceuticals position peaked at $38M in Q2 2026.
- 671 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.